Lv31
280 积分 2024-04-09 加入
Modeling the Exposure‐Response Relationship of Etanercept in the Treatment of Patients With Chronic Moderate to Severe Plaque Psoriasis
6小时前
待确认
Formatted anti–tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen‐induced arthritis
13天前
已完结
Efficacy of golimumab plus methotrexate in methotrexate-naïve patients with severe active rheumatoid arthritis
18天前
已完结
Telitacicept: First Approval
20天前
已完结
Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial
26天前
已完结
Certolizumab pegol
26天前
已完结
Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis
27天前
已完结
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
28天前
已完结
Pharmacokinetics and Safety of Golimumab, a Fully Human Anti‐TNF‐α Monoclonal Antibody, in Subjects With Rheumatoid Arthritis
1个月前
已完结
Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double‐blind, placebo‐controlled, dose‐ranging study
1个月前
已完结
皖公网安备34019202002308
